Fact sheet: Wldwide Hlthcare Tst PLC

Fund information
Fund name
Worldwide Healthcare Trust PLC Ord
Fund manager company
Frostrow Capital LLP
Fund type
Investment Trust
Fund managers
  • Sven H Borhosince 31/03/1995
  • Samuel D Isalysince 31/03/1995
Accolades
Fund objective
To provide long-term total return by investing predominantly in infrastructure, utility and related sectors mainly in emerging markets.
Benchmark
  • MSCI World Healthcare
Investment style
No data available.
Investment method
No data available.
Quick stats
1 Year return
11.8%
1 Year rank in sector
1/4
Sector
IT Biotechnology & Healthcare
Yield
0.8%
Ongoing charge (OCF)
?A fund’s ongoing charges figure (OCF) is similar to the old-style total expense ratio. It reflects the annual charge to investors in the fund, in percentage terms, but does not include extra performance-related fees (where these are levied) or the fund’s trading expenses on its underlying investments.
1%
Fund size
£941m
FE Risk score
?FE Risk Scores measure the riskiness of instruments relative to the FTSE 100 index of shares. Weekly volatility is measured over three years with recent behaviour counting more heavily than earlier behaviour. Cash-type investments will have scores close to zero. Funds will tend to have scores in the 0-150 range. The FTSE 100 is always scored at 100. There is no upper limit.
155
Mid price
2023
NAV
?Net asset value. The NAV per share may be higher or lower than the share price, which in turn is trading at either a discount or a premium to NAV.
2068.1
Discount/Premium
?When the market price of an investment trust’s shares is less than the net asset value (NAV) per share then it is trading at a discount to NAV. A trust’s shares are on a premium when they trade at a higher price than the NAV.
-1.89
Gearing
?Investment trusts have the ability to borrow money which they invest with the aim of generating a higher return than the cost of the loan. An ungeared trust has a figure of 100. A figure of 110 would represent a trust with 10% gearing.
113
Top in this sector
Fund name1 Year
Wldwide Hlthcare Tst PLC11.8%
Intl Biotechnology Trust7.6%
PlrCp GblHlthcr G&IPLC3.7%
The Biotech Growth Trust PLC2.2%
BB HlthcareTstPlcRedOrd1P-
...more in IT Biotechnology & Healthcare

Performance snapshot

Holdings snapshot

  • North America60.6%
    Europe16.6%
    Global Emerging Markets15.5%
    Asia7.3%
  • Large Cap Companies71.5%
    Small Cap Companies28.5%
  • North American Equities60.6%
    European Equities16.6%
    Global Emerging Market Equities15.5%
    Asia Pacific Equities7.3%

Performance vs Sector

Cumulative performance
 1 mth3 mth6 mth1 yr3 yr5 yr
Fund6.5%0.9%11.1%11.8%69.3%209.9%
Sector6.4%2.7%11.7%7.3%67.5%206.7%
Rank within sector3 / 43 / 42 / 41 / 42 / 43 / 4
Quartile3rd3rd2nd1st2nd3rd
Calendar performance
 YTD - 20162015201420132012
Fund5.2%13.9%39.6%47%20.3%
Sector3.2%12.7%39.3%43.2%27.5%
Rank within sector2 / 42 / 43 / 43 / 43 / 4
Quartile2nd2nd3rd3rd3rd
Risk statistics
Alpha
?Alpha is a measure of a fund's over- or under-performance by comparison to its benchmark. If the Alpha is 5, the fund has outperformed its benchmark by 5%; so the greater the Alpha, the greater the outperformance.
2.1
Beta
?Beta estimates a fund's volatility by comparison to that of its benchmark. A fund with a beta close to 1 means that the fund will move generally in line with the benchmark. Higher than 1 and the fund is more volatile than the benchmark and vice versa.
0.89
Sharpe
?This commonly-used measure calculates the level of return over and above the return of a notional risk-free investment, such as cash. The difference in returns is then divided by the fund's volatility. The resulting ratio is an indication of the amount of excess return generated per unit of risk.
0.81
Volatility
?Volatility (or standard deviation), when applied to an investment fund, expresses its risk. It shows how widely a range of returns varied from the fund's average return over a particular period. For example, if a fund had an average return of 5%, and its volatility was 15, this would mean that the range of its returns over the period had swung between +20% and -10%.
19.6
Tracking error
?This measures the standard deviation of a fund's excess returns over the returns of an index or benchmark portfolio. As such, it can be an indication of 'riskiness' in the manager's investment style. A Tracking Error below 2 suggests a passive approach. At 3 and above the the manager will be deploying a more active investment style.
6.53
Information ratio
?This is a useful risk-adjusted measure of actively managed fund performance. It is calculated by deducting the returns of the fund's benchmark from the fund's overall returns, then dividing the result by its tracking error. The higher the Information Ratio the better. It is generally considered that a figure of 0.5 reflects a good performance, 0.75 very good, and 1.00 outstanding.
0.01
R-Squared
?An indication of how closely correlated a fund is to an index or a benchmark. Values for R-Squared range between 0 and 1, with 0 indicating no correlation at all and 1 showing a perfect match. Values upwards of 0.7 suggest that the fund's behaviour is increasingly linked to its benchmark.
0.9
Price movement
52 week high2180
52 week low1596
Current bid price2022
Current offer price2027
Current mid price2023
Region
1North America60.6%
2Europe16.6%
3Global Emerging Markets15.5%
4Asia7.3%
Industry sector
1Large Cap Companies71.5%
2Small Cap Companies28.5%
Asset type
1North American Equities60.6%
2European Equities16.6%
3Global Emerging Market Equities15.5%
4Asia Pacific Equities7.3%
Individual holdings
1INTUITIVE SURGICAL INC4.3%
2BOSTON SCIENTIFIC CORP4.2%
3MERCK & CO INC(NEW)4.1%
4HCA HLDGS INC3.7%
5LILLY (ELI) & CO3.5%
6ALEXION PHARMACEUTICALS INC3.2%
7WRIGHT MEDICAL GROUP NV3.2%
8AMGEN INC2.9%
9BIOGEN INC2.8%
Management
Fund manager group
Frostrow Capital
Fund manager company
Frostrow Capital LLP
Fund type
Investment Trust
Fund objective
To provide long-term total return by investing predominantly in infrastructure, utility and related sectors mainly in emerging markets.
Benchmark
  • MSCI World Healthcare
Investment style
No data available.
Investment method
No data available.
Fund managers
NameSinceBiography
Sven H Borho31/03/1995Sven H. Borho, CFA, is a founding General Partner of OrbiMed. Mr. Borho is a portfolio manager for OrbiMed's public equity funds and he heads the firm's trading efforts. He started his career in 1991 when he joined Mehta and Isaly as a Senior Analyst covering European pharmaceutical firms and biotechnology companies worldwide. In 1993, Mr. Borho became portfolio manager to investment funds under management. Mr. Borho studied business administration at Bayreuth University in Germany and received a M. Sc. (Econ.) from The London School of Economics; he is a citizen of both Germany and Sweden.
Samuel D Isaly31/03/1995Samuel D. Isaly has been active in international and healthcare investment throughout his career, beginning at Chase Manhattan Bank. He studied international economics, mathematics and econometrics at Princeton and the London School of Economics. Mr Isaly joined SG Warburg and Company Inc in 1986 where he became a Senior Vice President. In March 1989, he became the initial founding partner of Mehta and Isaly. He became the initial founding partner of OrbiMed Capital LLc, created on January 1, 1998, upon the dissolution of Mehta and Isaly.
Compliance
AIC Member
Domicile
No data available.
Fund for sale in
United Kingdom
Worldwide Healthcare Trust PLC Ord
Initial charge-
Annual charge-
Min single investment£0
Min regular saving£0
Available in ISANo
Ongoing charge (OCF)-
Total expense ratio (TER)-
Bid price-
Offer price-
Mid price2063.94
CurrencyGBX
Price updated05/12/2016
TypeAccumulation
Institutional or retail classRetail
Domicile-
Citi codeNJEL
Worldwide Healthcare Trust PLC Sub
Initial charge-
Annual charge-
Min single investment£0
Min regular saving£0
Available in ISAYes
Ongoing charge (OCF)-
Total expense ratio (TER)-
Bid price560
Offer price618
Mid price589
CurrencyGBX
Price updated01/08/2014
Type-
Institutional or retail classRetail
Domicile-
Citi codeI7C5
Data provided by

The Content is only for your general information and use and is not intended to address your particular requirements. The Content does not constitute any form of advice, recommendation or arrangement by Moneywise and is not intended to be relied upon by you in making (or refraining from making) any specific investment or other decisions. Appropriate independent advice should be obtained before making any such decision.

This information is sourced from our partner Financial Express. We believe the data to be correct however you should take care in using any information.

You should be aware that prices may fall as well as rise and that the income derived can go down as well as up. When buying or selling any investment that fluctuates in price or value you may get back less than you invested. Past performance is not necessarily a guide to future performance.